Author: admin

“Prominent players in the medical robots market include Intuitive Surgical, Inc. (US), Stryker Corporation (US), Medtronic Plc (US), Smith & Nephew Plc (UK), Zimmer Biomet Holdings, Inc. (US), Asensus Surgical, Inc.(US), Zap Surgical Systems, Inc.(US)”

Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure. The adoption of medical robots is also expected to increase with the increasing need for automation in healthcare. However, the high cost of robotic systems may pose a challenge to the medical robots market during the forecast period.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2916860

Soft tissue surgical robotic system is the fastest growing in the medical robots market in 2023.

Based on type, the medical robots market is segmented into surgical robotic system, rehabilitation robotic systems, radiosurgery robotic systems, and hospital & pharmacy robotic systems. The surgical robotic systems have been further segmented into surgical robotic systems by application – soft tissue surgical robotic system (general surgery, gynecological surgery, urological surgery, and other applications) and hard tissue surgical robotic system (knee & hip surgery and spine surgery). The rehabilitation robotic systems have been further segmented into rehabilitation robotic systems by type – therapeutic robotic systems, assistive robotic systems, exoskeleton robotic systems, and other rehabilitation robotic systems. The hospital & pharmacy robotic systems have been further segmented into – pharmacy robotic systems (robotic dispensing systems, compounding robotic systems, and other pharmacy robotic systems) and hospital robotic systems (delivery robotic systems, telepresence robotic systems, diagnostic robotic systems, and other hospital robotic systems).

The soft tissue surgical robotic system sub-segment is the fastest growing surgical robotic system in the medical robots market in 2023, attributing to the increasing prevalence of various conditions such as cancer, appendicitis, obesity, and others. These conditions lead to increased demand for robot-assisted surgical procedures with higher accuracy.

Instruments & accessories are the largest product of the medical robots market in 2023.

Based on products & services, the medical robots market is segmented into robotic systems, instruments & accessories, and services. Among these, instruments and accessories segment accounted for the largest share of the medical robots market in 2023. The recurrent purchase of instruments & accessories to be used with the robotic systems instead of robotic systems leads to the higher adoption of this segment.

By end user, ambulatory surgery centers is the fastest growing in the medical robots market in 2023.

Based on end user, the medical robots market is segmented into hospitals & clinics, ambulatory surgery centers, pharmacies, rehabilitation centers, and other end users. The ambulatory surgery centers segment is expected to be the fastest growing segment of the market. The surgical procedures being offered by ASCs at a lower cost than hospitals drives the higher adoption of ambulatory surgery centers among patients.

North America dominates the global medical robots market in 2023.

The medical robots market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In 2023, North America accounted for the largest share of the medical robots market. As this region is home to a significant number of medical robots manufacturers. Moreover, the increasing adoption of robotic systems by hospitals in the country, the increasing volume of robotic-assisted surgical procedures, and the favourable reimbursement policies in the region, reinforces its position at the forefront of the medical robots market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=2916860

Medical Robots Market Dynamics:

Drivers:

1. Growing need to minimize medication errors

Restraints:

1. High cost of robotic systems

Opportunities:

1. Growth opportunities in emerging markets

Challenge:

1. Patient and provider acceptance

Key Market Players of Medical Robots Industry:

Prominent players in the medical robots market include Intuitive Surgical, Inc. (US), Stryker Corporation (US), Medtronic Plc (US), Smith & Nephew Plc (UK), Zimmer Biomet Holdings, Inc. (US), Asensus Surgical, Inc.(US), Zap Surgical Systems, Inc.(US), Renishaw Plc (UK), Hocoma Ag (Switzerland), Accuray Incorporated (US), Elekta (Sweden), Becton, Dickinson And Company (US), Omnicell, Inc. (US), Arxium (Canada), Ekso Bionics Holdings, Inc. (US), Bionik Laboratories Corp. (US), Lifeward, Inc. (Israel), Cyberdyne Inc.(Japan), Avateramedical Gmbh (Germany),Johnson & Johnson (US), and Swisslog Healthcare (Switzerland).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=2916860

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/medical-robotic-systems-market-2916860.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Medical Robots Market Growth, Drivers, and Opportunities | MarketsandMarkets™

“Browse 572 market data Tables and 58 Figures spread through 442 Pages and in-depth TOC on “Single-Use Bioreactors Market by Product (Systems, Bags, Assemblies), Type (Stirred Tank, Bubble-Column, Wave induced), Molecule (mAbs, Vaccines), Cell Type (Mammalian, Bacterial, Yeast), Application (R&D, Bioproduction) – Global Forecast to 2029″ View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/single-use-bioreactor-market-49113750.html”

The global Single Use Bioreactors Market is expected to grow from USD 4.4 billion in 2024 to USD 9.1 billion by 2029, at a CAGR of 15.4%. The single-use bioreactors (SUBs) market is driven by factors such as the growing adoption of single-use technologies by SMEs, CDMOs, and CMOs, the benefits of SUBs over traditional stainless-steel bioreactors, and the expanding biologics and biosimilars market. These bioreactors are favored for their lower capital investment, reduced water and energy consumption, and flexibility. However, challenges such as leachables and extractables issues, regulatory hurdles, and PFAS restrictions may impact growth. The market is bolstered by opportunities in hybrid facilities, which combine single-use and traditional systems for cost efficiency and flexibility. Despite these advantages, concerns about the potential breakage of single-use bags, which can lead to contamination and significant financial losses, pose challenges. In 2023, single-use bioreactor systems and stirred-tank bioreactors dominated the market, with North America leading regional markets due to its strong biopharmaceutical R&D presence. Key players include Sartorius AG, Danaher Corporation, Thermo Fisher Scientific Inc., and Merck KGaA.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750

Sartorius AG: Leading Provider of Single-Use Bioreactor Solutions

Sartorius AG is a prominent player in the single-use bioreactors market, catering to biopharmaceutical and pharmaceutical companies, CMOs, and CROs. The company stands out for its comprehensive range of customer-centric, technology-driven solutions and significant investments in R&D. Its extensive product lineup, which includes high-quality single-use bioreactors, is a key factor in its growing market share. Sartorius AG’s robust global presence and ongoing expansion in both developed and emerging markets position it for continued growth in the single-use bioreactors sector during the forecast period.

Danaher Corporation: Key Innovator in Single-Use Bioreactors

Danaher Corporation, through its subsidiary Cytiva, offers advanced cell culture, filtration, separation, and purification technologies for the medical, biopharmaceutical, and food & beverage industries. Its strong portfolio of single-use bioreactor solutions makes it a leading player in the market. Danaher’s bioprocessing technologies facilitate the development and commercialization of drugs, plasma, and vaccines, underscoring its significant role in the single-use bioreactors market.

Thermo Fisher Scientific, Inc.: Comprehensive Single-Use Bioreactor Solutions Provider

Thermo Fisher Scientific, Inc. provides a broad range of single-use bioreactor products, effectively addressing diverse market needs. As a leading market player, Thermo Fisher leverages its extensive product offerings and strong market presence to influence trends and customer preferences. Continuous investment in R&D enables the company to stay at the cutting edge of technological advancements, addressing emerging challenges and opportunities in bioprocessing.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750

Product Segmentation: Single-Use Bioreactor Systems Lead the Market

In 2023, the single-use bioreactors market is divided into several product categories: single-use bioreactor systems, single-use media bags, single-use assemblies, and other products (such as single-use vessels, sensors, tubing, connectors, software, control systems, and probes). The single-use bioreactor systems segment held the largest market share due to their lower initial investment requirements, reduced operational costs from simplified processes, and minimal environmental impact thanks to recyclable components. These advantages have significantly boosted the adoption of single-use bioreactor systems in biopharmaceutical applications.

Type Segmentation: Stirred-Tank Bioreactors Dominate

The single-use bioreactors market is segmented by type into stirred-tank, wave-induced, bubble-column, and other bioreactors (including hybrid designs and bioreactors with vertically perforated discs). In 2023, stirred-tank bioreactors represented the largest segment. Known for their versatility and scalability, stirred-tank bioreactors are extensively used in the pharmaceutical and biotechnology sectors. Their impeller-driven design ensures even distribution of gases and nutrients, making them ideal for producing recombinant proteins, vaccines, and monoclonal antibodies.

Molecule Type Segmentation: Monoclonal Antibodies Lead

The single-use bioreactors market is also segmented by molecule type into monoclonal antibodies (mAbs), vaccines, stem cells, gene-modified cells, and therapeutic proteins & peptides. In 2023, the monoclonal antibodies segment had the largest share, driven by the expanding pharmaceutical R&D pipeline, increasing cancer incidence, and rising demand for cancer therapies.

Cell Type Segmentation: Mammalian Cells Prevail

In terms of cell types, the market is divided into mammalian cells, bacterial cells, yeast cells, and other cells (such as insect and plant cells). The mammalian cells segment held the largest market share in 2023. This is due to the widespread use of mammalian cells in bioprocessing, known for their sophisticated metabolic functions, which drive the segment’s growth.

Application Segmentation: Bioproduction Leads

The market is segmented by application into bioproduction, process development, and research & development (R&D). The bioproduction segment accounted for the largest share in 2023, attributed to the growing use of single-use bioreactors in biomanufacturing, increased regulatory approvals for biopharmaceuticals, the rise of biosimilars, and patent expirations of blockbuster drugs.

End-User Segmentation: Pharmaceutical & Biotechnology Companies Dominate

Based on end users, the market is segmented into pharmaceutical & biotechnology companies, contract research organizations (CROs) & contract manufacturing organizations (CMOs), and academic & research institutes. The pharmaceutical & biotechnology companies segment was the largest in 2023 due to heightened R&D activities and increased production of biologics and biosimilars.

Regional Insights: North America and Asia Pacific Lead

The market is divided by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2023, North America held the largest market share, followed by Europe. North America’s substantial market share is driven by the presence of major players and growing demand for personalized medicine and biologics. Meanwhile, the Asia Pacific region is anticipated to experience the highest compound annual growth rate (CAGR), fueled by the rising demand for biosimilars, expanding biopharmaceutical manufacturing capacities, and a growing contract manufacturing sector.

For more information, inquire now! Inquire Now

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/single-use-bioreactor-market-49113750.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Single-Use Bioreactors Industry worth $9.1 billion by 2029, with a CAGR of 15.4%

“Growing Demand: The Healthcare Interoperability Solutions Market size is expected to grow at a compound annual growth rate (CAGR) of over 12.9% from 2022 to 2027. This growth is attributed to the rising demand for efficient healthcare data management and the need for improved patient care.”

The healthcare interoperability solutions industry is expected to grow significantly in the near future due to the increasing demand for healthcare data exchange and integration. The industry is driven by the growing focus on patient-centric care, increasing demand for cost-effective healthcare services, advances in technology, and the need for better analytics. The industry is expected to benefit from the development of standards-based technologies such as HL7 FHIR and IHE Profiles that enable healthcare organizations to easily share information. Additionally, healthcare organizations are increasingly turning to cloud-based solutions as a way to reduce costs and improve efficiency. Finally, the industry is expected to benefit from the adoption of blockchain technology, which can enable secure, end-to-end data exchange and integration of healthcare information.

Healthcare Interoperability Solutions Market in terms of revenue was estimated to be worth $3.4 billion in 2022 and is poised to reach $6.2 billion by 2027, growing at a CAGR of 12.9% from 2022 to 2027 according to a new report by MarketsandMarkets™. Growth in this market is driven by the increasing demand for efficient and cost-effictive healthcare delivery, government initiatives towards improving the healthcare interoperability. However, the lack of true interoperability among electric systems, financial burden and technical difficulties in building and operations are some factors restraining the growth of the healthcare interoperability solutions market to a certain extent during the forecast period. The base year considered for the study is 2021, while the forecast period is 2022 to 2027.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17705847

By type, the services segment accounted for the largest share of the healthcare interoperability solutions market in 2021.

On the basis of type: the services segment accounted for the largest share. The large share of this segment can be attributed to the advantages offered by the services such as installation, equipment updates or traditional licensing management are not required in case of services.

The healthcare providers segment is expected to witness the highest growth rate in the healthcare interoperability solutions market, by end user, during the forecast period

Based on end user: the healthcare providers segment is expected to register the highest CAGR during the forecast period. The growing geriatric population leading to the increasing hospital admissions is contributing to the growth of this segment.

North America dominated the healthcare interoperability solutions market in 2021

North America accounted for the largest share of the healthcare interoperability solutions market in 2021, followed by Europe and Asia Pacific. The rising demand for value-based healthcare, the need to reduce the increasing healthcare costs, and the implementation of favorable government initiatives & regulations in the region are the key factors responsible for the large share of North America in the healthcare interoperability solutions market.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=17705847

Healthcare Interoperability Solutions Market Dynamics:

Drivers:

1. Increasing demand for efficient and cost-effective healthcare delivery
2. Government initiatives and regulations to enhance patient care and safety
3. Emergence of new medical technologies
4. Growing adoption of electronic health records

Restraints:

1. Lack of accurate interoperability solutions across healthcare supply chain
2. Lack of standards and protocols in IT businesses
3. Use of outdated legacy systems in hospitals and clinic chains

Opportunities:

1. Growing markets for healthcare interoperability solutions in developing countries
2. Advancements in software technology for real-time data exchange

Challenges:

1. Increasing complexity due to lack of consistent data
2. Shortage of skilled healthcare IT professionals
3. Patient data security and privacy concerns in healthcare industry

Key Market Players:

Some of the prominent players in this market are Cerner Corporation (US), Epic Systems Corporation (US), Infor, Inc. (US), Koninklijke Philips NV (Netherlands), InterSystems Corporation (US), Orion Health Group Limited (New Zealand), IBM Watson Health (US), Lyniate (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), and Medical Information Technology, Inc. (US), iNTERFACEWARE (Canada), OSP Labs (US), ViSolve, Inc. (US), Jitterbit (US), Virtusa Corp. (US), and Summit Healthcare Services, Inc. (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=17705847

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/healthcare-interoperability-solution-market-17705847.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Healthcare Interoperability Solutions Market: Size and Share Insights

“The NGS sample preparation market is at the forefront of genomics innovation, fueled by declining sequencing costs, technological advancements, and rising demand for DNA-based research and diagnostics. With a projected CAGR of 13.4%, this market presents vast opportunities for companies aiming to lead in precision medicine and next-generation healthcare solutions.”

The NGS sample preparation industry is projected to witness considerable growth in the near future, with the increasing application of next-generation sequencing (NGS) in various areas of genomic research. Increased demand for NGS sample preparation technologies is expected to drive the growth of the industry. In addition, the rising number of NGS-based clinical applications, growth in the demand for personalized and precision medicine, and the availability of funding for research activities are some of the other major factors expected to drive the growth of the market. Furthermore, the emergence of new sample preparation technologies and the application of NGS in drug discovery are also expected to boost the growth of the market in the near future.

NGS Sample Preparation Market in terms of revenue was estimated to be worth $1.9 billion in 2022 and is poised to reach $4.0 billion by 2028, growing at a CAGR of 13.4% from 2022 to 2028 according to a new report by MarketsandMarkets™. Some of the prominent factors driving the growth of this market are advancements in NGS platforms, the declining cost of sequencing, the use of NGS as a substitute for PCR, as well as the increased efficiency of genotyping and preparation protocols for boosting the growth of the market. However, the presence of alternative technologies with limited expertise and sequence capabilities of individual laboratories can hamper the market growth.

DNA segment accounted for the largest share of the NGS sample preparation market

Based on the sample type, the NGS sample preparation market is segmented into DNA and RNA. In 2022, the DNA segment accounted for the largest share of the NGS sample preparation market. Growth in this market segment can be attributed to the rising number of cancer cases and growing R&D investments for studying DNA samples.

DNA fragmentation & library preparation is the fastest-growing workflow segment of the NGS sample preparation market

Based on workflow, the NGS sample preparation market is segmented into DNA fragmentation & library preparation, target enrichment, and quality control. In 2022, the DNA fragmentation &library segment accounted for the fastest-growing share of the workflow segment of NGS sample preparation market. Market growth can largely be attributed to the availability of new products, and advancements in the NGS protocols.

Asia Pacific: The fastest-growing region in the NGS sample preparation market.

The Asia Pacific NGS sample preparation market is projected to grow at the highest CAGR during the forecast period, mainly due to the rising focus on R&D activities, increasing adoption of NGS for diagnostics, and technological development in NGS data analysis.

Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=69735098

NGS Sample Preparation Market Dynamics:

Drivers:

1. Constant innovations in NGS platforms
2. Increased availability of advanced NGS systems at low costs
3. Use of NGS as substitute for PCR
4. Greater efficiency of genotyping and preparation protocols

Restraints:

1. Presence of alternative technologies
2. Limited expertise and sequencing capabilities of individual laboratories

Opportunities:

1. Increasing collaborations and partnerships among key players

Challenges:

1. Ethical and privacy issues in health data

Key Market Players:

The market for NGS sample preparation is highly consolidated, with key players strategizing to capture the market. Prominent players in the NGS sample preparation market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), PerkinElmer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Merck KGAA (Germany), QIAGEN (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Eurofins Scientific (Luxembourg), BGI (China), 10x Genomics (US), Sysmex Corporation (US), Psomagen (US), Zymo Research Corporation (US), Takara Bio Inc. (Japan), Novogene Co., Ltd. (China), New England Biolabs (US), Tecan Trading AG (US), Oxford Nanopore Technologies PLC (UK), PacBio (US), Medgenome (US), and Swift Biosciences Inc. (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=69735098

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/ngs-sample-preparation-market-69735098.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: NGS Sample Preparation Market worth $4.0 billion by 2028 | MarketsandMarkets